GASTROINTESTINAL STROMAL TUMORS
Clinical trials for GASTROINTESTINAL STROMAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug tested for Hard-to-Treat stomach tumors shows limited promise
Disease control CompletedThis study tested whether the drug nilotinib could help control advanced gastrointestinal stromal tumors (GIST) in adults who had not yet received treatment for their metastatic disease. It enrolled 34 patients to take nilotinib daily and measured if their tumors shrank or stoppe…
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Real-World cancer drug study completes with 61 patients
Disease control CompletedThis study observed how the drug avapritinib worked for Chinese patients with a specific type of stomach and intestinal cancer called GIST in real-world hospital settings. It involved 61 patients with different genetic types of the tumor to see how safe the drug was and how well …
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug duo tested in fight against tough stomach tumors
Disease control CompletedThis study tested whether combining two drugs, avelumab and axitinib, could help control advanced gastrointestinal stromal tumors (GIST) that had worsened after standard treatments. It involved 58 adults whose cancer had progressed despite prior therapy. The main goal was to see …
Matched conditions: GASTROINTESTINAL STROMAL TUMORS
Phase: PHASE2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC